ADVERTISEMENT

HCLTech Q4 Results Review: IDBI Capital Upgrades The Stock To 'Buy', Says AI Infusion Fuels Growth Momentum

IDBI Capital sees HCLTech as a relative outperformer among peers.

<div class="paragraphs"><p>HCL secured net new deals worth $2.99 billion in TCV, driven by a mega deal, taking FY25 TCV to $9.4 billion.(Photo Source: HCLTech)</p></div>
HCL secured net new deals worth $2.99 billion in TCV, driven by a mega deal, taking FY25 TCV to $9.4 billion.(Photo Source: HCLTech)
HCLTech management guided 2–5% CC revenue growth, including 4.1% organic and 50bps inorganic contribution. Ebit margin guidance remains at 18–19%. An additional 1% impact is expected from acquisitions, with Q1 projected to outperform YoY despite typical seasonality.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit